カテゴリ： 世界, 医療/バイオ, Market Monitor Global

黄体形成ホルモン放出拮抗薬のグローバル市場展望 2023年-2029年：ホルモン療法、免疫療法、標的療法、化学療法、その他

■ 英語タイトル：Luteinizing Hormone-Releasing Antagonist Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC14408）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC14408
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品
■ ページ数：70
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[黄体形成ホルモン放出拮抗薬のグローバル市場展望 2023年-2029年：ホルモン療法、免疫療法、標的療法、化学療法、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の黄体形成ホルモン放出拮抗薬市場規模と予測を収録しています。・世界の黄体形成ホルモン放出拮抗薬市場：売上、2018年-2023年、2024年-2029年
・世界の黄体形成ホルモン放出拮抗薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の黄体形成ホルモン放出拮抗薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ホルモン療法」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

黄体形成ホルモン放出拮抗薬のグローバル主要企業は、Johnson & Johnson、 Astellas Pharma Inc、 Ipsen Pharma、 Sanofi、 Bayer AG、 AstraZeneca、 Pfizer、 Teva Pharmaceutical Industries、 Abbott、 GlaxoSmithKlineなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、黄体形成ホルモン放出拮抗薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の黄体形成ホルモン放出拮抗薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の黄体形成ホルモン放出拮抗薬市場：タイプ別市場シェア、2022年
・ホルモン療法、免疫療法、標的療法、化学療法、その他

世界の黄体形成ホルモン放出拮抗薬市場：用途別、2018年-2023年、2024年-2029年
世界の黄体形成ホルモン放出拮抗薬市場：用途別市場シェア、2022年
・病院薬局、小売薬局、オンライン薬局

世界の黄体形成ホルモン放出拮抗薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の黄体形成ホルモン放出拮抗薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における黄体形成ホルモン放出拮抗薬のグローバル売上、2018年-2023年
・主要企業における黄体形成ホルモン放出拮抗薬のグローバル売上シェア、2022年
・主要企業における黄体形成ホルモン放出拮抗薬のグローバル販売量、2018年-2023年
・主要企業における黄体形成ホルモン放出拮抗薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Johnson & Johnson、 Astellas Pharma Inc、 Ipsen Pharma、 Sanofi、 Bayer AG、 AstraZeneca、 Pfizer、 Teva Pharmaceutical Industries、 Abbott、 GlaxoSmithKline

*************************************************************

・調査・分析レポートの概要
黄体形成ホルモン放出拮抗薬市場の定義
市場セグメント
世界の黄体形成ホルモン放出拮抗薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の黄体形成ホルモン放出拮抗薬市場規模
世界の黄体形成ホルモン放出拮抗薬市場規模：2022年 VS 2029年
世界の黄体形成ホルモン放出拮抗薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの黄体形成ホルモン放出拮抗薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の黄体形成ホルモン放出拮抗薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：ホルモン療法、免疫療法、標的療法、化学療法、その他
黄体形成ホルモン放出拮抗薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院薬局、小売薬局、オンライン薬局
黄体形成ホルモン放出拮抗薬の用途別グローバル売上・予測

・地域別市場分析
地域別黄体形成ホルモン放出拮抗薬市場規模 2022年と2029年
地域別黄体形成ホルモン放出拮抗薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Johnson & Johnson、 Astellas Pharma Inc、 Ipsen Pharma、 Sanofi、 Bayer AG、 AstraZeneca、 Pfizer、 Teva Pharmaceutical Industries、 Abbott、 GlaxoSmithKline
...

This research report provides a comprehensive analysis of the Luteinizing Hormone-Releasing Antagonist market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Luteinizing Hormone-Releasing Antagonist market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Luteinizing Hormone-Releasing Antagonist, challenges faced by the industry, and potential opportunities for market players.
The global Luteinizing Hormone-Releasing Antagonist market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Luteinizing Hormone-Releasing Antagonist market presents opportunities for various stakeholders, including Hospital Pharmacies, Retail Pharmacies. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Luteinizing Hormone-Releasing Antagonist market. Additionally, the growing consumer demand present avenues for market expansion.
The global Luteinizing Hormone-Releasing Antagonist market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Luteinizing Hormone-Releasing Antagonist market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Luteinizing Hormone-Releasing Antagonist market.
Market Overview: The report provides a comprehensive overview of the Luteinizing Hormone-Releasing Antagonist market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Hormonal Therapy, Immunotherapy), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Luteinizing Hormone-Releasing Antagonist market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Luteinizing Hormone-Releasing Antagonist market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Luteinizing Hormone-Releasing Antagonist market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Luteinizing Hormone-Releasing Antagonist market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Luteinizing Hormone-Releasing Antagonist market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Luteinizing Hormone-Releasing Antagonist market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Luteinizing Hormone-Releasing Antagonist, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Luteinizing Hormone-Releasing Antagonist market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Luteinizing Hormone-Releasing Antagonist market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Hormonal Therapy
Immunotherapy
Targeted Therapy
Chemotherapy
Others
Market segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Luteinizing Hormone-Releasing Antagonist Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Johnson & Johnson
Astellas Pharma Inc
Ipsen Pharma
Sanofi
Bayer AG
AstraZeneca
Pfizer
Teva Pharmaceutical Industries
Abbott
GlaxoSmithKline
Outline of Major Chapters:
Chapter 1: Introduces the definition of Luteinizing Hormone-Releasing Antagonist, market overview.
Chapter 2: Global Luteinizing Hormone-Releasing Antagonist market size in revenue and volume.
Chapter 3: Detailed analysis of Luteinizing Hormone-Releasing Antagonist manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Luteinizing Hormone-Releasing Antagonist in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Luteinizing Hormone-Releasing Antagonist capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Luteinizing Hormone-Releasing Antagonist Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Luteinizing Hormone-Releasing Antagonist Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Luteinizing Hormone-Releasing Antagonist Overall Market Size
2.1 Global Luteinizing Hormone-Releasing Antagonist Market Size: 2022 VS 2029
2.2 Global Luteinizing Hormone-Releasing Antagonist Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Luteinizing Hormone-Releasing Antagonist Sales: 2018-2029
3 Company Landscape
3.1 Top Luteinizing Hormone-Releasing Antagonist Players in Global Market
3.2 Top Global Luteinizing Hormone-Releasing Antagonist Companies Ranked by Revenue
3.3 Global Luteinizing Hormone-Releasing Antagonist Revenue by Companies
3.4 Global Luteinizing Hormone-Releasing Antagonist Sales by Companies
3.5 Global Luteinizing Hormone-Releasing Antagonist Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Luteinizing Hormone-Releasing Antagonist Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Luteinizing Hormone-Releasing Antagonist Product Type
3.8 Tier 1, Tier 2 and Tier 3 Luteinizing Hormone-Releasing Antagonist Players in Global Market
3.8.1 List of Global Tier 1 Luteinizing Hormone-Releasing Antagonist Companies
3.8.2 List of Global Tier 2 and Tier 3 Luteinizing Hormone-Releasing Antagonist Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Luteinizing Hormone-Releasing Antagonist Market Size Markets, 2022 & 2029
4.1.2 Hormonal Therapy
4.1.3 Immunotherapy
4.1.4 Targeted Therapy
4.1.5 Chemotherapy
4.1.6 Others
4.2 By Type – Global Luteinizing Hormone-Releasing Antagonist Revenue & Forecasts
4.2.1 By Type – Global Luteinizing Hormone-Releasing Antagonist Revenue, 2018-2023
4.2.2 By Type – Global Luteinizing Hormone-Releasing Antagonist Revenue, 2024-2029
4.2.3 By Type – Global Luteinizing Hormone-Releasing Antagonist Revenue Market Share, 2018-2029
4.3 By Type – Global Luteinizing Hormone-Releasing Antagonist Sales & Forecasts
4.3.1 By Type – Global Luteinizing Hormone-Releasing Antagonist Sales, 2018-2023
4.3.2 By Type – Global Luteinizing Hormone-Releasing Antagonist Sales, 2024-2029
4.3.3 By Type – Global Luteinizing Hormone-Releasing Antagonist Sales Market Share, 2018-2029
4.4 By Type – Global Luteinizing Hormone-Releasing Antagonist Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Luteinizing Hormone-Releasing Antagonist Market Size, 2022 & 2029
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application – Global Luteinizing Hormone-Releasing Antagonist Revenue & Forecasts
5.2.1 By Application – Global Luteinizing Hormone-Releasing Antagonist Revenue, 2018-2023
5.2.2 By Application – Global Luteinizing Hormone-Releasing Antagonist Revenue, 2024-2029
5.2.3 By Application – Global Luteinizing Hormone-Releasing Antagonist Revenue Market Share, 2018-2029
5.3 By Application – Global Luteinizing Hormone-Releasing Antagonist Sales & Forecasts
5.3.1 By Application – Global Luteinizing Hormone-Releasing Antagonist Sales, 2018-2023
5.3.2 By Application – Global Luteinizing Hormone-Releasing Antagonist Sales, 2024-2029
5.3.3 By Application – Global Luteinizing Hormone-Releasing Antagonist Sales Market Share, 2018-2029
5.4 By Application – Global Luteinizing Hormone-Releasing Antagonist Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Luteinizing Hormone-Releasing Antagonist Market Size, 2022 & 2029
6.2 By Region – Global Luteinizing Hormone-Releasing Antagonist Revenue & Forecasts
6.2.1 By Region – Global Luteinizing Hormone-Releasing Antagonist Revenue, 2018-2023
6.2.2 By Region – Global Luteinizing Hormone-Releasing Antagonist Revenue, 2024-2029
6.2.3 By Region – Global Luteinizing Hormone-Releasing Antagonist Revenue Market Share, 2018-2029
6.3 By Region – Global Luteinizing Hormone-Releasing Antagonist Sales & Forecasts
6.3.1 By Region – Global Luteinizing Hormone-Releasing Antagonist Sales, 2018-2023
6.3.2 By Region – Global Luteinizing Hormone-Releasing Antagonist Sales, 2024-2029
6.3.3 By Region – Global Luteinizing Hormone-Releasing Antagonist Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Luteinizing Hormone-Releasing Antagonist Revenue, 2018-2029
6.4.2 By Country – North America Luteinizing Hormone-Releasing Antagonist Sales, 2018-2029
6.4.3 US Luteinizing Hormone-Releasing Antagonist Market Size, 2018-2029
6.4.4 Canada Luteinizing Hormone-Releasing Antagonist Market Size, 2018-2029
6.4.5 Mexico Luteinizing Hormone-Releasing Antagonist Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Luteinizing Hormone-Releasing Antagonist Revenue, 2018-2029
6.5.2 By Country – Europe Luteinizing Hormone-Releasing Antagonist Sales, 2018-2029
6.5.3 Germany Luteinizing Hormone-Releasing Antagonist Market Size, 2018-2029
6.5.4 France Luteinizing Hormone-Releasing Antagonist Market Size, 2018-2029
6.5.5 U.K. Luteinizing Hormone-Releasing Antagonist Market Size, 2018-2029
6.5.6 Italy Luteinizing Hormone-Releasing Antagonist Market Size, 2018-2029
6.5.7 Russia Luteinizing Hormone-Releasing Antagonist Market Size, 2018-2029
6.5.8 Nordic Countries Luteinizing Hormone-Releasing Antagonist Market Size, 2018-2029
6.5.9 Benelux Luteinizing Hormone-Releasing Antagonist Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Luteinizing Hormone-Releasing Antagonist Revenue, 2018-2029
6.6.2 By Region – Asia Luteinizing Hormone-Releasing Antagonist Sales, 2018-2029
6.6.3 China Luteinizing Hormone-Releasing Antagonist Market Size, 2018-2029
6.6.4 Japan Luteinizing Hormone-Releasing Antagonist Market Size, 2018-2029
6.6.5 South Korea Luteinizing Hormone-Releasing Antagonist Market Size, 2018-2029
6.6.6 Southeast Asia Luteinizing Hormone-Releasing Antagonist Market Size, 2018-2029
6.6.7 India Luteinizing Hormone-Releasing Antagonist Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Luteinizing Hormone-Releasing Antagonist Revenue, 2018-2029
6.7.2 By Country – South America Luteinizing Hormone-Releasing Antagonist Sales, 2018-2029
6.7.3 Brazil Luteinizing Hormone-Releasing Antagonist Market Size, 2018-2029
6.7.4 Argentina Luteinizing Hormone-Releasing Antagonist Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Luteinizing Hormone-Releasing Antagonist Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Luteinizing Hormone-Releasing Antagonist Sales, 2018-2029
6.8.3 Turkey Luteinizing Hormone-Releasing Antagonist Market Size, 2018-2029
6.8.4 Israel Luteinizing Hormone-Releasing Antagonist Market Size, 2018-2029
6.8.5 Saudi Arabia Luteinizing Hormone-Releasing Antagonist Market Size, 2018-2029
6.8.6 UAE Luteinizing Hormone-Releasing Antagonist Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Company Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Luteinizing Hormone-Releasing Antagonist Major Product Offerings
7.1.4 Johnson & Johnson Luteinizing Hormone-Releasing Antagonist Sales and Revenue in Global (2018-2023)
7.1.5 Johnson & Johnson Key News & Latest Developments
7.2 Astellas Pharma Inc
7.2.1 Astellas Pharma Inc Company Summary
7.2.2 Astellas Pharma Inc Business Overview
7.2.3 Astellas Pharma Inc Luteinizing Hormone-Releasing Antagonist Major Product Offerings
7.2.4 Astellas Pharma Inc Luteinizing Hormone-Releasing Antagonist Sales and Revenue in Global (2018-2023)
7.2.5 Astellas Pharma Inc Key News & Latest Developments
7.3 Ipsen Pharma
7.3.1 Ipsen Pharma Company Summary
7.3.2 Ipsen Pharma Business Overview
7.3.3 Ipsen Pharma Luteinizing Hormone-Releasing Antagonist Major Product Offerings
7.3.4 Ipsen Pharma Luteinizing Hormone-Releasing Antagonist Sales and Revenue in Global (2018-2023)
7.3.5 Ipsen Pharma Key News & Latest Developments
7.4 Sanofi
7.4.1 Sanofi Company Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Luteinizing Hormone-Releasing Antagonist Major Product Offerings
7.4.4 Sanofi Luteinizing Hormone-Releasing Antagonist Sales and Revenue in Global (2018-2023)
7.4.5 Sanofi Key News & Latest Developments
7.5 Bayer AG
7.5.1 Bayer AG Company Summary
7.5.2 Bayer AG Business Overview
7.5.3 Bayer AG Luteinizing Hormone-Releasing Antagonist Major Product Offerings
7.5.4 Bayer AG Luteinizing Hormone-Releasing Antagonist Sales and Revenue in Global (2018-2023)
7.5.5 Bayer AG Key News & Latest Developments
7.6 AstraZeneca
7.6.1 AstraZeneca Company Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Luteinizing Hormone-Releasing Antagonist Major Product Offerings
7.6.4 AstraZeneca Luteinizing Hormone-Releasing Antagonist Sales and Revenue in Global (2018-2023)
7.6.5 AstraZeneca Key News & Latest Developments
7.7 Pfizer
7.7.1 Pfizer Company Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Luteinizing Hormone-Releasing Antagonist Major Product Offerings
7.7.4 Pfizer Luteinizing Hormone-Releasing Antagonist Sales and Revenue in Global (2018-2023)
7.7.5 Pfizer Key News & Latest Developments
7.8 Teva Pharmaceutical Industries
7.8.1 Teva Pharmaceutical Industries Company Summary
7.8.2 Teva Pharmaceutical Industries Business Overview
7.8.3 Teva Pharmaceutical Industries Luteinizing Hormone-Releasing Antagonist Major Product Offerings
7.8.4 Teva Pharmaceutical Industries Luteinizing Hormone-Releasing Antagonist Sales and Revenue in Global (2018-2023)
7.8.5 Teva Pharmaceutical Industries Key News & Latest Developments
7.9 Abbott
7.9.1 Abbott Company Summary
7.9.2 Abbott Business Overview
7.9.3 Abbott Luteinizing Hormone-Releasing Antagonist Major Product Offerings
7.9.4 Abbott Luteinizing Hormone-Releasing Antagonist Sales and Revenue in Global (2018-2023)
7.9.5 Abbott Key News & Latest Developments
7.10 GlaxoSmithKline
7.10.1 GlaxoSmithKline Company Summary
7.10.2 GlaxoSmithKline Business Overview
7.10.3 GlaxoSmithKline Luteinizing Hormone-Releasing Antagonist Major Product Offerings
7.10.4 GlaxoSmithKline Luteinizing Hormone-Releasing Antagonist Sales and Revenue in Global (2018-2023)
7.10.5 GlaxoSmithKline Key News & Latest Developments
8 Global Luteinizing Hormone-Releasing Antagonist Production Capacity, Analysis
8.1 Global Luteinizing Hormone-Releasing Antagonist Production Capacity, 2018-2029
8.2 Luteinizing Hormone-Releasing Antagonist Production Capacity of Key Manufacturers in Global Market
8.3 Global Luteinizing Hormone-Releasing Antagonist Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Luteinizing Hormone-Releasing Antagonist Supply Chain Analysis
10.1 Luteinizing Hormone-Releasing Antagonist Industry Value Chain
10.2 Luteinizing Hormone-Releasing Antagonist Upstream Market
10.3 Luteinizing Hormone-Releasing Antagonist Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Luteinizing Hormone-Releasing Antagonist Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Luteinizing Hormone-Releasing Antagonist in Global Market
Table 2. Top Luteinizing Hormone-Releasing Antagonist Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Luteinizing Hormone-Releasing Antagonist Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Luteinizing Hormone-Releasing Antagonist Revenue Share by Companies, 2018-2023
Table 5. Global Luteinizing Hormone-Releasing Antagonist Sales by Companies, (K Units), 2018-2023
Table 6. Global Luteinizing Hormone-Releasing Antagonist Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Luteinizing Hormone-Releasing Antagonist Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Luteinizing Hormone-Releasing Antagonist Product Type
Table 9. List of Global Tier 1 Luteinizing Hormone-Releasing Antagonist Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Luteinizing Hormone-Releasing Antagonist Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Luteinizing Hormone-Releasing Antagonist Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Luteinizing Hormone-Releasing Antagonist Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Luteinizing Hormone-Releasing Antagonist Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Luteinizing Hormone-Releasing Antagonist Sales (K Units), 2018-2023
Table 15. By Type - Global Luteinizing Hormone-Releasing Antagonist Sales (K Units), 2024-2029
Table 16. By Application – Global Luteinizing Hormone-Releasing Antagonist Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Luteinizing Hormone-Releasing Antagonist Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Luteinizing Hormone-Releasing Antagonist Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Luteinizing Hormone-Releasing Antagonist Sales (K Units), 2018-2023
Table 20. By Application - Global Luteinizing Hormone-Releasing Antagonist Sales (K Units), 2024-2029
Table 21. By Region – Global Luteinizing Hormone-Releasing Antagonist Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Luteinizing Hormone-Releasing Antagonist Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Luteinizing Hormone-Releasing Antagonist Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Luteinizing Hormone-Releasing Antagonist Sales (K Units), 2018-2023
Table 25. By Region - Global Luteinizing Hormone-Releasing Antagonist Sales (K Units), 2024-2029
Table 26. By Country - North America Luteinizing Hormone-Releasing Antagonist Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Luteinizing Hormone-Releasing Antagonist Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Luteinizing Hormone-Releasing Antagonist Sales, (K Units), 2018-2023
Table 29. By Country - North America Luteinizing Hormone-Releasing Antagonist Sales, (K Units), 2024-2029
Table 30. By Country - Europe Luteinizing Hormone-Releasing Antagonist Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Luteinizing Hormone-Releasing Antagonist Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Luteinizing Hormone-Releasing Antagonist Sales, (K Units), 2018-2023
Table 33. By Country - Europe Luteinizing Hormone-Releasing Antagonist Sales, (K Units), 2024-2029
Table 34. By Region - Asia Luteinizing Hormone-Releasing Antagonist Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Luteinizing Hormone-Releasing Antagonist Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Luteinizing Hormone-Releasing Antagonist Sales, (K Units), 2018-2023
Table 37. By Region - Asia Luteinizing Hormone-Releasing Antagonist Sales, (K Units), 2024-2029
Table 38. By Country - South America Luteinizing Hormone-Releasing Antagonist Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Luteinizing Hormone-Releasing Antagonist Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Luteinizing Hormone-Releasing Antagonist Sales, (K Units), 2018-2023
Table 41. By Country - South America Luteinizing Hormone-Releasing Antagonist Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Luteinizing Hormone-Releasing Antagonist Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Luteinizing Hormone-Releasing Antagonist Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Luteinizing Hormone-Releasing Antagonist Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Luteinizing Hormone-Releasing Antagonist Sales, (K Units), 2024-2029
Table 46. Johnson & Johnson Company Summary
Table 47. Johnson & Johnson Luteinizing Hormone-Releasing Antagonist Product Offerings
Table 48. Johnson & Johnson Luteinizing Hormone-Releasing Antagonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Johnson & Johnson Key News & Latest Developments
Table 50. Astellas Pharma Inc Company Summary
Table 51. Astellas Pharma Inc Luteinizing Hormone-Releasing Antagonist Product Offerings
Table 52. Astellas Pharma Inc Luteinizing Hormone-Releasing Antagonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Astellas Pharma Inc Key News & Latest Developments
Table 54. Ipsen Pharma Company Summary
Table 55. Ipsen Pharma Luteinizing Hormone-Releasing Antagonist Product Offerings
Table 56. Ipsen Pharma Luteinizing Hormone-Releasing Antagonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Ipsen Pharma Key News & Latest Developments
Table 58. Sanofi Company Summary
Table 59. Sanofi Luteinizing Hormone-Releasing Antagonist Product Offerings
Table 60. Sanofi Luteinizing Hormone-Releasing Antagonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Sanofi Key News & Latest Developments
Table 62. Bayer AG Company Summary
Table 63. Bayer AG Luteinizing Hormone-Releasing Antagonist Product Offerings
Table 64. Bayer AG Luteinizing Hormone-Releasing Antagonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Bayer AG Key News & Latest Developments
Table 66. AstraZeneca Company Summary
Table 67. AstraZeneca Luteinizing Hormone-Releasing Antagonist Product Offerings
Table 68. AstraZeneca Luteinizing Hormone-Releasing Antagonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. AstraZeneca Key News & Latest Developments
Table 70. Pfizer Company Summary
Table 71. Pfizer Luteinizing Hormone-Releasing Antagonist Product Offerings
Table 72. Pfizer Luteinizing Hormone-Releasing Antagonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Pfizer Key News & Latest Developments
Table 74. Teva Pharmaceutical Industries Company Summary
Table 75. Teva Pharmaceutical Industries Luteinizing Hormone-Releasing Antagonist Product Offerings
Table 76. Teva Pharmaceutical Industries Luteinizing Hormone-Releasing Antagonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Teva Pharmaceutical Industries Key News & Latest Developments
Table 78. Abbott Company Summary
Table 79. Abbott Luteinizing Hormone-Releasing Antagonist Product Offerings
Table 80. Abbott Luteinizing Hormone-Releasing Antagonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Abbott Key News & Latest Developments
Table 82. GlaxoSmithKline Company Summary
Table 83. GlaxoSmithKline Luteinizing Hormone-Releasing Antagonist Product Offerings
Table 84. GlaxoSmithKline Luteinizing Hormone-Releasing Antagonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. GlaxoSmithKline Key News & Latest Developments
Table 86. Luteinizing Hormone-Releasing Antagonist Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 87. Global Luteinizing Hormone-Releasing Antagonist Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Luteinizing Hormone-Releasing Antagonist Production by Region, 2018-2023 (K Units)
Table 89. Global Luteinizing Hormone-Releasing Antagonist Production by Region, 2024-2029 (K Units)
Table 90. Luteinizing Hormone-Releasing Antagonist Market Opportunities & Trends in Global Market
Table 91. Luteinizing Hormone-Releasing Antagonist Market Drivers in Global Market
Table 92. Luteinizing Hormone-Releasing Antagonist Market Restraints in Global Market
Table 93. Luteinizing Hormone-Releasing Antagonist Raw Materials
Table 94. Luteinizing Hormone-Releasing Antagonist Raw Materials Suppliers in Global Market
Table 95. Typical Luteinizing Hormone-Releasing Antagonist Downstream
Table 96. Luteinizing Hormone-Releasing Antagonist Downstream Clients in Global Market
Table 97. Luteinizing Hormone-Releasing Antagonist Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Luteinizing Hormone-Releasing Antagonist Segment by Type in 2022
Figure 2. Luteinizing Hormone-Releasing Antagonist Segment by Application in 2022
Figure 3. Global Luteinizing Hormone-Releasing Antagonist Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Luteinizing Hormone-Releasing Antagonist Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Luteinizing Hormone-Releasing Antagonist Revenue, 2018-2029 (US$, Mn)
Figure 7. Luteinizing Hormone-Releasing Antagonist Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Luteinizing Hormone-Releasing Antagonist Revenue in 2022
Figure 9. By Type - Global Luteinizing Hormone-Releasing Antagonist Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Luteinizing Hormone-Releasing Antagonist Revenue Market Share, 2018-2029
Figure 11. By Type - Global Luteinizing Hormone-Releasing Antagonist Sales Market Share, 2018-2029
Figure 12. By Type - Global Luteinizing Hormone-Releasing Antagonist Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Luteinizing Hormone-Releasing Antagonist Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Luteinizing Hormone-Releasing Antagonist Revenue Market Share, 2018-2029
Figure 15. By Application - Global Luteinizing Hormone-Releasing Antagonist Sales Market Share, 2018-2029
Figure 16. By Application - Global Luteinizing Hormone-Releasing Antagonist Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Luteinizing Hormone-Releasing Antagonist Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Luteinizing Hormone-Releasing Antagonist Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Luteinizing Hormone-Releasing Antagonist Revenue Market Share, 2018-2029
Figure 20. By Region - Global Luteinizing Hormone-Releasing Antagonist Sales Market Share, 2018-2029
Figure 21. By Country - North America Luteinizing Hormone-Releasing Antagonist Revenue Market Share, 2018-2029
Figure 22. By Country - North America Luteinizing Hormone-Releasing Antagonist Sales Market Share, 2018-2029
Figure 23. US Luteinizing Hormone-Releasing Antagonist Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Luteinizing Hormone-Releasing Antagonist Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Luteinizing Hormone-Releasing Antagonist Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Luteinizing Hormone-Releasing Antagonist Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Luteinizing Hormone-Releasing Antagonist Sales Market Share, 2018-2029
Figure 28. Germany Luteinizing Hormone-Releasing Antagonist Revenue, (US$, Mn), 2018-2029
Figure 29. France Luteinizing Hormone-Releasing Antagonist Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Luteinizing Hormone-Releasing Antagonist Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Luteinizing Hormone-Releasing Antagonist Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Luteinizing Hormone-Releasing Antagonist Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Luteinizing Hormone-Releasing Antagonist Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Luteinizing Hormone-Releasing Antagonist Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Luteinizing Hormone-Releasing Antagonist Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Luteinizing Hormone-Releasing Antagonist Sales Market Share, 2018-2029
Figure 37. China Luteinizing Hormone-Releasing Antagonist Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Luteinizing Hormone-Releasing Antagonist Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Luteinizing Hormone-Releasing Antagonist Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Luteinizing Hormone-Releasing Antagonist Revenue, (US$, Mn), 2018-2029
Figure 41. India Luteinizing Hormone-Releasing Antagonist Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Luteinizing Hormone-Releasing Antagonist Revenue Market Share, 2018-2029
Figure 43. By Country - South America Luteinizing Hormone-Releasing Antagonist Sales Market Share, 2018-2029
Figure 44. Brazil Luteinizing Hormone-Releasing Antagonist Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Luteinizing Hormone-Releasing Antagonist Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Luteinizing Hormone-Releasing Antagonist Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Luteinizing Hormone-Releasing Antagonist Sales Market Share, 2018-2029
Figure 48. Turkey Luteinizing Hormone-Releasing Antagonist Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Luteinizing Hormone-Releasing Antagonist Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Luteinizing Hormone-Releasing Antagonist Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Luteinizing Hormone-Releasing Antagonist Revenue, (US$, Mn), 2018-2029
Figure 52. Global Luteinizing Hormone-Releasing Antagonist Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Luteinizing Hormone-Releasing Antagonist by Region, 2022 VS 2029
Figure 54. Luteinizing Hormone-Releasing Antagonist Industry Value Chain
Figure 55. Marketing Channels


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • セザリー症候群治療の世界市場2023年：放射線療法、化学療法、免疫療法、体外光化学療法
  • 膵臓がん転移治療の世界市場2023年：化学療法、標的療法、その他
  • 世界のホルモン放出IUD市場2022年：市場規模予測（～2028年）
  • 世界のゴナドトロピン放出ホルモン拮抗薬市場2022年：市場規模予測（～2028年）
  • カルシウムチャネル拮抗薬のグローバル市場展望 2023年-2029年：ジヒドロピリジン、非ジヒドロピリジン
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23DC14408 )"黄体形成ホルモン放出拮抗薬のグローバル市場展望 2023年-2029年：ホルモン療法、免疫療法、標的療法、化学療法、その他" (英文：Luteinizing Hormone-Releasing Antagonist Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。